Cardiovascular Events (CV)
Showing 1 - 25 of >10,000
Tonometry(1) and Duplex Ultrasound(2) to Predict CV Events in to
Recruiting
- Abdominal Aortic Aneurysm
- Cardiovascular Events
- Carotid Artery Reactivity test (CAR test)
- Arterial Stiffness
-
Nijmegen, Gelderland, Netherlands
- +6 more
Nov 10, 2022
Tonometry and Duplex Ultrasound to Predict AAA Progression and
Active, not recruiting
- Abdominal Aortic Aneurysm
- Cardiovascular Events
- Carotid Artery Reactivity test (CAR test)
- Arterial stiffness
-
Nijmegen, Gelderland, Netherlands
- +2 more
Sep 23, 2021
Inclisiran on Major Adverse Cardiovascular Events in French
Not yet recruiting
- Atherosclerotic Cardiovascular Disease
- Inclisiran sodium
- +3 more
- (no location specified)
Jul 26, 2023
Diabetes, Type 2, PreDiabetes, Metabolic Syndrome Trial (The Cleerly CAD Staging System)
Not yet recruiting
- Diabetes Mellitus, Type 2
- +2 more
- The Cleerly CAD Staging System
- (no location specified)
Oct 31, 2023
Primary Prevention of Atherosclerotic Cardiovascular Disease Trial (Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran)
Not yet recruiting
- Primary Prevention of Atherosclerotic Cardiovascular Disease
- Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL
- Placebo in 1.5ml
- (no location specified)
Feb 13, 2023
Primary Cardiovascular Events Using the Multimarker Approach
Completed
- Cardiovascular Diseases
- +4 more
- measurement of multiple biomarkers
- (no location specified)
Jan 19, 2023
Sars-CoV2, Covid19, Cardiovascular Diseases Trial in Barcelona
Active, not recruiting
- Sars-CoV2
- +3 more
-
Barcelona, Catalonia, SpainHospital Clínic of Barcelona
Aug 22, 2022
N-terminal Pro-B-type Natriuretic Peptide in Type 2 Diabetes
Recruiting
- Type2diabetes
- +2 more
-
Singapore, SingaporeSingapore General Hospital
Feb 22, 2023
Cardiovascular Risk, Cardiovascular Prevention Trial in United States (CV Prevention Choice Tool, Implementation Facilitation
Enrolling by invitation
- Cardiovascular Risk
- Cardiovascular Prevention
- CV Prevention Choice Tool
- Implementation Facilitation Strategies
-
Marietta, Georgia
- +3 more
Sep 3, 2022
Heart Diseases, Diabetes, Type 2, Pre-diabetes Trial in Minneapolis (Cardiovascular Risk Homeless Support)
Active, not recruiting
- Heart Diseases
- +4 more
- Cardiovascular Risk Homeless Support
-
Minneapolis, MinnesotaHennepin Healthcare Research Institute
Aug 29, 2023
Obesity Trial (Naltrexone-Bupropion (NB) Combination, Placebo)
Not yet recruiting
- Obesity
- Naltrexone-Bupropion (NB) Combination
- Placebo
- (no location specified)
Oct 18, 2023
Prediction of Cardiovascular Events
Recruiting
- Cardiovascular Diseases
- additional blood samples
-
Toulouse, FranceUniversity Hospital Toulouse
May 17, 2022
Arteriosclerosis, Hypercholesterolaemia Trial (MK-0616, Placebo)
Not yet recruiting
- Arteriosclerosis
- Hypercholesterolaemia
- MK-0616
- Placebo
- (no location specified)
Aug 17, 2023
Diabetes, Type 2, Major Adverse Cardiac Events Trial in Hangzhou (CGM)
Not yet recruiting
- Diabetes Mellitus, Type 2
- Major Adverse Cardiac Events
- CGM
-
Hangzhou, Chinathe Second Affiliated Hospital Zhejiang University Schoolof Medi
Sep 23, 2023
Frailty on Cardiovascular Events and Mortality in COPD.
Not yet recruiting
- Role of Frailty in COPD
- Assessment of cardiovascular events, cardiovascular mortality, all-cause mortality, and mortality due to COPD at 12 and 24 months
- (no location specified)
Jun 19, 2023
Triglyceride-Glucose Index on Cardiovascular Outcomes in
Not yet recruiting
- Major Cardiovascular Events
- Triglyceride glucose index TyG
- (no location specified)
Oct 6, 2023
Novel Cardiovascular Biomarkers in Patients With Kidney Disease
Not yet recruiting
- Haemodialysis Complication
- Major Adverse Cardiac Events
- Cardiac Biomarkers
- +2 more
- (no location specified)
Sep 14, 2023
Cardiovascular Diseases, Uric Acid Trial (Allopurinol 200 mg, Optional intervention)
Not yet recruiting
- Cardiovascular Diseases
- Uric Acid
- Allopurinol 200 mg
- Optional intervention
- (no location specified)
Jul 5, 2023
CV Imaging of Metabolic Interventions
Recruiting
- Bariatric Surgery Candidate
- +2 more
- MRI
-
Cleveland, OhioCardiovascular Innovation Research Center
Dec 5, 2022
Cardiovascular Diseases Trial in Nassau (Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte))
Recruiting
- Cardiovascular Diseases
- Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte)
-
Nassau, The Bahamas, BahamasThe Partners Clinical Research Centre at The Medical Pavilion
Oct 17, 2023
Troponin to Detect Major Cardiovasculaire Advserse Events on
Recruiting
- Cancer
- +2 more
- No intervention
-
Paris, FranceInstitut Mutualiste Montsouris
Aug 22, 2023
Patient-Perceived Versus Trial in Shatin (Cardiovascular prevention guidelines)
Not yet recruiting
- Patient-Perceived Versus
- Cardiovascular prevention guidelines
-
Shatin, Hong KongThe Chinese University of Hong Kong
Jan 12, 2023
Suspicion of Cardiovascular Events on Immunecheckpoint
Recruiting
- Cancer
- +3 more
- No intervention for research purposes only
-
Paris, FranceIntitut Mutualiste Montsouris
Mar 23, 2023
Cardiovascular Diseases Trial in Shatin (TQJ230, Placebo)
Active, not recruiting
- Cardiovascular Diseases
- TQJ230
- Placebo
-
Shatin, Hong KongThe Chinese University of Hong Kong
Sep 16, 2022